Skip to content

Clinical trials

Lung Neoplasms trials in New Zealand

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Country / region: New Zealand Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20101
20123
20151
20161
20171
20201
20211
20242
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Terminated5
Recruiting3
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Checkpoint Therapeutics, Inc.3
Achieve Life Sciences1
BeOne Medicines1
Bristol-Myers Squibb1
CSL Behring1
Eli Lilly and Company1
European Organisation for Research and Treatment of Cancer - EORTC1
Hoffmann-La Roche1
Merck Sharp & Dohme LLC1
Middlemore Hospital, New Zealand1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms17
Carcinoma, Non-Small-Cell Lung12
Neoplasms3
Melanoma2
Neoplasm Metastasis2
Skin Neoplasms2
Adenocarcinoma1
Adenocarcinoma of Lung1
Cachexia1
Carcinoma1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.